|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A double-blind,randomised,placebo-controlled phaseⅢintergroup study of gefitinib in patients with advanced NSCLC,non-progressing after first line platinum-based chemotherapy(EORTC 08021/ILCP 01/03)显示文摘 | Gaafar RM Surmont VF Scagliotti GV | | 0，，： | 1 |
| 2 | A double-blind, randomised,placebo-controlled phase ID intergroupstudy of gefitinib in patients with advanced NSCLC, non-pro-gressing after first line platinum-based chemotherapy(EORTC 08021/ILCP 01/03) 显示文摘 | Gaafar RM Sunnont VF Scagliotti GV | 2011 | Eur J Cancer2011，47，15： | 1 |
| 3 | Phase II study of first-line bortezomiband cisplatin in malignant pleural mesothelioma and prospective validationof progression free survival rate as a primary end-point for mesotheliomaclinical trials (European Organisation for Research and Treatment ofCancer 08052)显示文摘 | O'Brien RM Gaafar S Popat | 2013 | Eur J Cancer2013，49，13： | 1 |
| 4 | A double- blind, randomized,placebo-controlled phase Ⅲ intergroup study of gefitinib in patients with advanced NSCLC on- progressing after first-line platinum-based chemotherapy ( EORTC08021/ILCPO1/03 ) 显示文摘 | Gaafar RM Surmont VF Scagliotti GV | 2011 | Eur J Cancer2011，47，15： | 1 |
| 5 | A double- blind, randomised, placebo- controlled phase II1 intergroup study of gefitinib in patients with advanced NSCLC, non- progressing after first line platinum- based chemotherapy (EORTC 08021/ILCP 01/03)显示文摘 | GAAFAR RM SURMONT VF SCAGLIOTI GV et 01 | 2011 | Eur J Cancer2011，47，15： | 1 |
| 6 | A double-blind, randomised, placebo-controlled phase ill intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCPOl/03) 显示文摘 | Gaafar RM Surmont VF Scagliotti GV | 2011 | Eur J Cancer2011，47，15： | 1 |
| 7 | A double-blind, randomised,placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum- based chemotherapy (EORTC 08021/ILCP 01/03) 显示文摘 | H Gaafar RM Surmont VF Scagliotti GV | 2011 | Eur J Cancer2011，47，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员